Establishment Labs Holdings Inc. (NASDAQ:ESTA) is Pura Vida Investments LLC’s Largest Position

Pura Vida Investments LLC trimmed its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 41.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 113,041 shares of the company’s stock after selling 78,898 shares during the period. Establishment Labs comprises about 16.5% of Pura Vida Investments LLC’s investment portfolio, making the stock its biggest position. Pura Vida Investments LLC’s holdings in Establishment Labs were worth $5,208,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the business. Simplify Asset Management Inc. raised its holdings in Establishment Labs by 197.1% during the 4th quarter. Simplify Asset Management Inc. now owns 64,300 shares of the company’s stock valued at $2,962,000 after buying an additional 42,661 shares during the period. KLP Kapitalforvaltning AS bought a new position in Establishment Labs in the 4th quarter worth about $161,000. Sei Investments Co. grew its stake in Establishment Labs by 22.3% in the fourth quarter. Sei Investments Co. now owns 42,471 shares of the company’s stock worth $1,957,000 after purchasing an additional 7,731 shares in the last quarter. William Blair Investment Management LLC raised its position in Establishment Labs by 44.1% during the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock valued at $37,447,000 after purchasing an additional 248,888 shares in the last quarter. Finally, Royce & Associates LP purchased a new position in shares of Establishment Labs during the fourth quarter valued at $4,862,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Stock Performance

Shares of ESTA stock opened at $40.43 on Friday. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The business has a fifty day moving average of $36.36 and a 200 day moving average of $40.81. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of -15.67 and a beta of 0.95. Establishment Labs Holdings Inc. has a 1 year low of $28.16 and a 1 year high of $60.12.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.34). The company had revenue of $44.51 million during the quarter, compared to analysts’ expectations of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. As a group, research analysts expect that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Stephens restated an “overweight” rating and set a $52.00 price objective on shares of Establishment Labs in a research note on Thursday, March 6th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.